Skip to content
Cisterna Biologics logo

Cisterna Biologics

Cisterna Biologics is a YC Summer 2022 (S22) company. Based in San Diego, CA, USA. Team of 2.

  • Synthetic Biology
  • Biotech
  • Therapeutics

About Cisterna Biologics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Cisterna Biologics manufactures high-purity mRNA and RNA products for biotech and pharmaceutical researchers developing RNA-based therapeutics, diagnostics, and vaccines. Its proprietary synthesis methods eliminate contaminants, including double-stranded RNA and endotoxins, at their source rather than through downstream purification steps. This removes the need for standard HPLC purification and plasmid-based bacterial amplification, which are the conventional approaches researchers rely on today.

Business model

Per-order pricing on off-the-shelf and custom RNA synthesis products.

Go-to-market

Biotech and pharmaceutical researchers buy directly through the Cisterna Biologics website, choosing between off-the-shelf RNA products and custom synthesis orders.

From the Y Combinator listing

How Cisterna Biologics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

High quality mRNA for therapeutic application

Founded in 2022 and based in San Diego, California, Cisterna Biologics is a technology company. It aims to solve some of the challenges currently facing the biotech industry to develop mRNA-based therapeutics – quality, quantity, longevity and cost of mRNA. As mRNA technology matures, it becomes imperative that these issues are solved so we can fully explore mRNA's endless possibilities as a therapeutic. Cisterna uses proprietary technologies to either remove a contaminant at its source or replace the source itself. For example, to remove double-stranded RNA (dsRNA), we use ribozymes - molecular scissors - to precisely cut the mRNA at its 3’ end. This assures not only 3’ homogeneity, but also eliminates dsRNA, which are primarily produced due to self-templated additions at the 3’ end. Utilizing a PCR-like system to amplify the DNA template in large quantities eliminates the requirement for plasmid enrichment in bacteria, the prime source of endotoxin contamination. These are just a few examples of Cisterna’s powerful technologies being used to achieve our goal of 10x higher quality mRNA for therapeutic application.

Facts

Industry
Healthcare / Healthcare
Location
San Diego, CA, USA
Team size
2
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works